Match Document Document Title
5015631 Repairing agent for cells and tissues  
A repairing agent for cells and tissues is disclosed, which agent comprises, as an active ingredient, a compound of the general formula: ##STR1## wherein Z represents lithium, potassium, sodium,...
5013661 Lipopolysaccharide-specific acyloxyacyl hydrolase  
An acyloxyacyl hydrolase from the human promyelocyte cell line HL-60 has been found to specifically hydrolyze fatty acids from their ester linkages to hydroxy groups of 3-hydroxyfatty acids, the...
5013724 Process for the sulfation of glycosaminoglycans, the sulfated glycosaminoglycans and their biological applications  
According to the process of the invention, a glycosaminoglycan is used in the form of a salt soluble in an organic medium and is subjected to the action of a given sulfation agent.
5013716 Unpleasant taste masking compositions and methods for preparing same  
The present invention pertains to an unpleasant taste masking composition which comprises a flavoring agent having a bitter taste or unpleasant off-note and a sufficient amount of a non-bitter...
5013715 Pasty organopolysiloxane composition  
The pasty organopolysiloxane composition is compounded from a methyl phenyl polysiloxane fluid and 5 to 50% by weight of a fatty acid ester of saccharose. The composition is highly transparent and...
5010059 Pharmaceutical products and lactosyl compounds  
The compounds of the formula I exert a pronounced specific cytoprotective effect; they can be used for the treatment of acute and chronic inflammations and organ ischemias caused by narrowing of...
5006514 α,α-trehalose trimycolates and pharmaceutical compositions  
An α,α-trehalose trimycolate represented by formula: ##STR1## (wherein R 1 through R 8 each represents a hydrogen atom or mycolic acid residue, and three of R 1 through R 8 are mycolic acid...
5001114 Alkyl mono and polyglycoside phosphate esters  
New alkyl mono and polyglycoside phosphate esters and anionic derivatives thereof are described which compounds have the general formula RO(G) x Z y wherein G is a glycosyl moiety which is...
4999340 Rehydratable agarose gels  
The present invention involves a method for separating biological molecules by subjection of said molecules to a separation system in a gel medium. The method most particularly involves the use of...
4996196 Novel desiccant and dehydration therewith  
There are disclosed a novel desiccant containing anhydrous maltose and dehydration of hydrous matters, e.g. food, pharmaceutical and cosmetic, therewith. Such hydrous matters are dehydrated without...
4988679 Liquid sustained release composition  
There is provided an orally ingestible liquid composition for suspending therein an orally administrable pharmaceutically active composition releasable over an extended period of time comprises...
4983584 Therapeutic and prophylactic agents for peptic ulcers  
A therapeutic and prophylactic agent for peptic ulcers comprising as an effective ingredient a cyclohexane derivative represented by general formula (I): ##STR1## wherein A represents a group shown...
4983583 Granulated compositions of polysaccharides, process for their preparation and use  
The present invention relates to granulated compositions of thickening and viscosity-raising polysaccharides having few anionic groups, wherein the polysaccharide particles are coated with...
4980462 Antiviral agents  
A second-step virus binding receptor is found in nature on the surface of animal and plant cells. This receptor is thought to be needed for virus penetration into target cells. The second-step...
4980175 Liquid orally administrable compositions based on edible oils  
Orally ingestible liquid compositions for suspending therein orally administrable pharmaceutically active compositions comprising triglycerides, propylene glycol ester, or monoacetylated glycerides...
4975281 Anti-ulcer composition  
In accordance with the present invention a novel oral composition and method of using same for the treatment of ulcers and other gastrointestinal disorders is disclosed. The composition comprises...
4962093 Thiabendazole-containing antifungal composition  
An antifungal agent comprising thiabendazole and a sucrose fatty acid ester, preferably, a sucrose ester of a fatty acid the residue of which has 8-18 carbon atoms.
4962092 Compositions for treating duodenal ulcers  
Anti-anal leakage agents are used in combination with vitamin-fortified liquid fatty acid polyester compositions to provide pharmaceutical and food compositions for treating duodenal ulcers while...
4952687 Fatty acid esters of sugars and sugar alcohols  
The oxidative stability of esters of unsaturated fatty acids and polyols having from 4-8 hydroxyl groups, preferably of sugars or sugar alcohols, more preferably of sucrose, is improved if the...
4950653 Solid iodophor composition  
A solid iodophor composition contains a water-soluble iodophor, especially povidone iodine, and at least one of a urea and a sugar alcohol, especially mannitol, sorbitol or xylitol. The composition...
4950654 Hydrophilic theophylline powder formulation and its preparation  
A hydrophilic theophylline powder formulation consisting of (a) from 5 to 15% by weight of theophylline, (b) from 15 to 30% by weight of lechithin, (c) from 45 to 80% by weight of sugar, ...
4946832 Cosmetic base composition with therapeutic properties  
Cosmetic Base composition exhibiting therapeutic properties comprising an acyl fatty acid alpha-hydroxy carboxylic acid ester or alkali metal salt thereof, a sucrose fatty acid ester, and a solvent.
4946830 Agent and method for the prevention of metastases of malignant tumors  
Agents and methods for the prevention of metastases of malignant tumors use the monosaccharides which are specific for organ cell lectins and/or glycoconjugates containing these monosaccharides,...
4945085 Use of sucralfate for controlling emesis and/or diarrhea  
Sucralfate can be used to control and treat emesis and/or diarrhea in veterinary medicine.
4945084 Method and composition for topically treating anorectal or other dermal wounds  
Hemorrhoidal compositions containing disaccharide polysulfate-aluminum compounds such as sucralfate, alone or in combination with other hemorrhoidal products, as an agent effective for alleviating...
4938961 Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia  
An organ preservation solution, particularly valuable in the preservation of mammalian hearts intended for transplantation, in aqueous solution, at least about 3% by weight of polypropylene glycol...
4937234 Minerals in bioavailable form  
A soluble mineral in bioavailable form is formed from a mineral salt of a carboxylic acid derivative of a pentose or hexose such as zinc gluconate and an amino acid having the ability of stabilize...
4931554 Method of preparing a solid composition of lactulose, and composition so obtained  
The invention relates to a method of preparing a solid composition of lactulose in a simple way. According to the invention lactulose syrup is mixed with Fiberform®, i.e. a fibre product based on...
4921838 Angiogenic and blood perfusion inducing properties of amphiphilic compounds  
A method for enhancing angiogenesis and/or blood vascular perfusion in mammals by administering a pharmacologically effective amount of specific angiogenically active non-ionic, anionic, cationic...
4912093 Use of synthetic sulfated saccharides to enhance wound healing  
The use of sulfated oligosaccharides, particularly mono- and disaccharides, and their salts to enhance healing of wounds is described. Preferred saccharides are those having three or more sulfate...
4895838 Method for provoking angiogenesis by administration of angiogenically active oligosaccharides  
A method for causing or increasing angiogenesis is described. The method involves administering to a subject, such as a human being in need of angiogenesis an angiogenically effective amount of an...
4886168 Device designed to preserve cosmetic substances that can be frozen  
The present invention concerns a container containing dehydrated cosmetic substances placed in a case and ampoules of physiological serum or some other solution. These substances, stored at ambient...
4885282 Treatment of hyperhidrosis, ichthyosis and wrinkling  
Skin suffering from emotional hyperhidrosis, ichthyosis with or without keratosis, and intrinsic or photoaging wrinkling is treated with mono- or discarboxylic acids containing 4 to 18 carbon...
4885281 Sucralfate suspension  
The invention relates to formulations in the form of suspensions containing sucralfate, characterized in that they contain, based on the sucralfate, 1-5% by weight of xanthan gum and 1-12.5% by...
4880786 Additive solution for blood preservation and activation  
There is disclosed an additive solution for blood preservation and activation, which comprises a phosphoenolpyruvic acid represented by the following formula (I): ##STR1## wherein R 1 represents a...
4879280 Dialysis solution for use in intraperitoneal dialysis  
An aqueous solution for use in intraperitoneal dialysis made up of least one substance for regulation of the electrolyte balance in the body of the patient has a saccharide with at least one...
4873229 Galacto-oligosaccharide containing feed  
A stock feed containing a specific amount of galacto-oligosaccharides, the stock feed being effective in the prevention of scours/loose passage of livestocks and thus in the increase of their weight.
4870059 Dehydration of hydrous matter with anhydrous maltose  
There are disclosed a novel desiccant containing anhydrous maltose and dehydration of hydrous matters, e.g. food, pharmaceutical and cosmetic, therewith. Such hydrous matters are dehydrated without...
4851338 Method for diagnosing the presence of bacteria  
A composition for therapeutic or diagnostic use in regard to pathogenic microorganisms, containing as an active constituent a structural element having the formula: ##STR1## wherein R 1 , R 2 , R 3...
4851392 Ingestible aggregate and delivery system prepared therefrom  
The present invention relates to an ingestible aggregate comprising a pre-swelled substantially anhydrous hydrocolloid and a substrate. More particularly this invention relates to an aggregate...
4839347 Composition for treating dehydration  
Composition for treating dehydration in swine is described according to the preferred embodiment of the teachings of the present invention for adminstration in the drinking water or feed of pigs....
4835142 Powdery pharmaceutical composition suitable for application to mucosa of oral or nasal cavity  
A powdery pharmaceutical composition for application to the mucosa of the oral or nasal cavity including: (a) a base selected from the group consisting of lower alkyl ethers of cellulose; (b) a...
4826962 Tetrachlororaffinose and its use in the preparation of sucralose  
The novel chlorinated sugar O-α-D-6-chloro-6-deoxygalactopyranosyl-(1➝6)-α-D-4-chlo ro-4-deoxygalactopyranosyl-(1➝2)-β-D-1, 6-dichloro-1, 6-dideoxyfructofuranoside (TCR) can be used to...
4826825 Dehydration of hydrous product using anhydrous lactitol  
A novel dehydration process using anhydrous lactitol as the desiccant is disclosed. Anhydrous lactitol is converted into the crystalline hydrate and acts as the desiccant when incorporated into a...
4816445 Crystalline alpha-maltose  
A crystalline alpha-maltose with an alpha-maltose isomer content of 55% or higher is prepared by the process comprising preparing a high-concentration syrup, with a moisture content lower than 10...
4814347 Anthelmintic spiroketals and method of use  
This invention pertains to a new method for killing and controlling worms (Helminths), new formulations for killing and controlling worms in animals, new chemical compounds, and a new synthesis of...
4812444 Dehydration of hydrous matter using anhydrous glycosylfructose  
A novel dehydration method using anhydrous glycosylfructose as the desiccant is disclosed. Anhydrous glycosylfructose is converted to the crystalline hydrate and acts as the desiccant when...
4810827 Dehydration of hydrous matter using anhydrous aldohexose  
A novel dehydration process using anhydrous aldohexose as the desiccant is disclosed. Anhydrous aldohexose is converted to crystalline hydrate and acts as the desiccant when it is incorporated into...
4782045 Promoting the proliferation of intestinal bifidobacteria  
The present invention provides a method for promoting the proliferation of microorganisms of the genus Bifidibacterium comprising contacting said microorganisms with a growth promoting effective...
4761400 Laxative composition based on lactulose and its preparation process  
Lactulose-based laxative composition which is in the form of a jelly with a viscosity at 20° C. measured on the Brookfield viscosimeter between 15,000 and 30,000 centipoises, a refractive index at...